Laparoscopic liver resection for malignancy: A review of the literature

Table 1 Published studies of laparoscopic liver resection for malignancy

Ref.	Year	n	HCC	CRM	GB CA	Cholangio	Lypmhoma	NET mets	Other	Size (cm)	EBL (mL)	Conversion	OT (min)	M	Death	LOS (d)	Margin (cm)
Choi et al[23]	2013	57	57	0		0	0	0	0	0.8-5.5	150-800	NA	95-380	NA	0	5 17	2.08 ± 1.68
Guerron et al[63]	2013	40		40						3.3	376 ± 122	5%	239 ± 17	15%	NA	3.7	1 ± 0.2
Gumbs et al[21]	2012	40	4	30	6	1		4	5	NA	300	6%	265	11.30%	NA	6 (1-31)	NA
Abu Hilal et al[13]	2012	133	18	83		2	2	17	11	0.5-14	(10-4000)	NA	30-540	0 40 %	NA	0 15	Pos 0-35%
Topal et al[24]	2012	81								NA	50 (10-300)	NA	120 (80-200)	11%	0	5 (3-7)	NA
Yoon et al[25]	2012	89	89							3 ± 1.6	NA	4.70%	2675 ± 138	NA	NA	NA	1.4 ± 1.4
Cannon et al[26]	2012	35		35						NA	202	NA	NA	23%	0	4.8 vs 8.3	Neg 97%
Ikeda et al[27]	2012	30	16	13		1				2.6 ± 1	146 (0-550)	0	79-697	NA	0	5-44	5 (1-30)
Dagher et al[28]	2010	163	163							3.6 (1-20)	250 (30-2000)	9.20%	180 (60-655)	11.60%	1.20%	7 (2-76)	12 (0-58)
Shafaee et al[29]	2011	66	3	55			1	3	2	0.5-12.5	300 (0-5000)	11%	180 (80-570)	26%	0	6 (2-42)	0.3 (0-4)
Lai et al[30]	2011	56	42	14						0.9-5.4	175 (5-2000)	3.60%	150 (75-307)	14.30%	0	6.5 (2-13)	89.3% R0
Belli et al[31]	2011	65	65							3.8 (1-9)	311 ± 180	10.70%	NA	20%	1.50%	8.2 (3-15)	NA
Truant et al[32]	2011	36	36							2.9 ± 1.2	452 ± 442	19.40%	NA	25	0	NA	0.95
Nguyen et al[43]	2011	108								3.2	101	NA	256	NA	NA	NA	1.12, 1.5
Lee et al[33]	2011	31	31							2.5 (1.5-9)	150 (10-1610)	18.20%	225 (100-420)	6.10%	0	5 (2-15)	1.8 (0-4)
Hu et al[34]	2011	30	30							6.7 ± 3.1	520 ± 30	NA	180 ± 45	13.30%	NA	13 ± 2.1	NA
Kazaryan et al[35]	2010	107		107						3 (0.5-12)	300 (50-4000)	4.20%	188 (64-488)	NA	0.90%	3 (1-42)	NA
Martin et al[5]	2010	65	14%	48%		12%			26%	4 (2-15)	150 (20-1000)	4%	140 (50-240)	23%	1%	3 (1-13)	Pos 3%
Zhang et al[41]	2010	70	29	28		2	1		10	NA		8.80%	150 (20-390)	14.80%	0	6 (1-20)	Neg 100%
Tranchart et al[36]	2010	42	42							3.58 ± 1.75	346 ± 435.7	NA	233.1 ± 92.7	20.40%	2.40%	6.7 ± 5.9	1.04 ± 0.8
Yoon et al[8]	2010	69	69							3.1 ± 1.5		7.20%	280.9 ± 128.2	21.70%	NA	9.9 ± 5.6	1.5 ± 1.6
Nguyen et al[62]	2009	109		109						NA	200 (20-2500)	3.70%	234 (60-555)	12.00%	NA	4 (1-22)	Neg 94.4%
Sasaki et al[37]	2009	72	37	35						2.5 (1.5-8.5)	64 (1-917)	NA	177 (70-430)	5.50%	NA	8.5-10	0.6 (0-4)
Bryant et al[16]	2009	100	64	22		3			11	NA	(0-2000)	9.60%	30-480	15.10%	0	7.9 (2-76)	1.53 (0-5.8)
Inagaki et al[38]	2009	52	36	10		3			3	3.1 ± 1.8	393 ± 564	2.90%	214 ± 93	10%	NA	17	NA
Cho et al[4]	2009	35	27	8						3.4 (1.5-7.5)	619.5 (20-1800)	NA	299.9 (80-630)	27.50%	NA	10.9 (5-38)	1.3 (0.2-5)
Huang et al[39]	2009	33	27	3		1			2	3.4 (1-11)	200 (100-400)	6.70%	120 (90-177.5)	11.11%	NA	5	0.2-3.2
Otsuka et al[40]	2009	76	55	16		2			3	3.68 ± 2.8	262 ± 344.8	NA	268 ± 123.1	11%	0	11.8 ± 7.3	NA
Castaing et al[14]	2009	60		60						3.3 ± 1.1	NA	10%	NA	27%	1.70%	10 (5-50)	Neg 87%
Dagher et al[3]	2009	210								NA	300 ± 391	12%	250 ± 103.8	22%	1.00%	6 ± 3.5	10.5 ± 13.6
Zhang et al[41]	2009	49	33	10		6			3	6.2 (0.8-15)	280 (10-1000)	NA	NA	NA	0	NA	1.2 (0.5-6)
Cho et al[42]	2008	71	52	19						3.7 ± 3	425 (20-900)	5%	240 (30-540)	15%	0	9 (4-21)	1 (0.3-6.8)
Topal et al[6]	2008	77								3.8 (0.5-17)	500 (10-7000)	9%	95 (30-385)	5.50%	NA	6 (0-41)	Pos in 1.2%
Chen et al[53]	2008	116	116							1.3-5.1	101.6-667.2	NA	118.4-488.7	6%	NA	6	NA
Buell et al[17]	2008	106	36	31		8			31	3.1-6.4		NA	NA	NA	3.70%	NA	2.80%
Hompes et al[22]	2007	45	8	32	1	4		1	1	4 (0.8-17)	200 (5-4000)	6.60%	115 (45-360)	24%	0	7 (3-41)	1 (0.1-3)
Dagher et al[47]	2007	38	24	9		3			2	3.8 (2.2-8)	397 (100-2300)	10%	227 ± 109	16%	1.40%	5.9 ± 5.6	1.1 (0.1-3.2)
Koffron et al[48]	2007	103								NA	102	6% to ha	99	9.30%	0	NA	NA
Vibert et al[9]	2006	65	16	41		2		3	3	0.8-18	NA	13%	85-515	19%	1.10%	11 (3-47)	NA
Mala et al[10]	2005	47	1	42				1	3	3 (0.8-15)	700 (< 100-5000)	6%	187 (80-334)	16%	0	3.5 (1-14)	Pos in 6%
O'Rourke et al[7]	2004	33		22					11	NA	20-2000	9.40%	40-370	14%	0	NA	1.1 (0-3)
Inagaki et al[45]	2003	52	36							3.1 (1-14)	393 ± 564 (5-3500)	2.90%	214 (61-375)	26.40%	0	14.8	NA
Gigot et al[59]	2002	37	10	12				5	10	3.3 (1-6)	NA	10.80%	NA	21%	0	7 (2-16)	Pos in 6.7%

HCC: Hepatocellular carcinoma; CRM: Colorectal metastasis; NET mets: Neuroendocrine metastasis; GB CA: Gallbladder adenocarcinoma; Cholangio: Cholangiocarcinoma; NA: Unavailable; EBL: Estimated blood loss; OT: Operative time; LOS: Length of stay; Margin: Resection margin size; Pos: Positive margin rate; R0: R0 resection rate.